DALLAS - Melynda Geurts, chief operating officer of global patient recruitment and retention provider D. Anderson & Company, will be among the guest speakers for the SMi 6th Annual Conference on Accelerating Patient Recruitment and Retention in Clinical Trials March 24-25, 2010, at the Crowne Plaza St. James Hotel in London. The conference will delve into latest developments in patient recruitment and retention including the influences of the Internet and social media. Other key topics include protocol planning, recruitment metrics, regulatory and ethical considerations, global enrollment strategies, enrollment feasibility, emerging markets, and marketing strategies.
Geurts’ presentation, titled International Issues: Budgeting and Contracting in Patient Recruitment for Global Clinical Trials, will examine the complexities of global patient recruitment in the context of culture, government regulations and geography.
“The regulatory and ethical climates relating to recruitment practices vary widely, and dissecting the regulations and guidelines pertaining to patient recruitment can be daunting,” she said. “Every country has a history, experience and research culture which demands a customized approach to recruitment.”
D. Anderson & Company is an international player with more than 18 years of experience in 66 countries and 40 therapeutic areas. The company evolved from a site management organization and niche CRO to its current status as one of the largest privately held patient recruitment and retention firms in the United States. In 2008, Dallas Business Journal named DAC one of the 50 Largest Women-Owned Businesses in Dallas-Ft. Worth.
About D. Anderson & Company
With offices in Seattle, Houston and Dallas, DAC is a subsidiary of D.L. Anderson International. The company is certified as a Women-Owned Business (WBE) by the Women’s Business Enterprise National Council and a continuing education provider through the California Board of Registered Nursing. For more information, visit www.dandersoncompany.com.
